Indigenous Bloom Hemp Corp. (OTCPK: VRTH.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Indigenous Bloom Hemp Corp. (OTCPK: VRTH.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $71.00.
trading between 0.00 and 0.00.
Tweenvest scores Indigenous Bloom Hemp Corp. across four factors: quality 5/100. Its strongest factor is quality.
VRTH.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $71.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- -395.85
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 71.14M
- Employees
- —
- Next earnings
- —
About Indigenous Bloom Hemp Corp.
Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. The company is headquartered in Kelowna, Canada.
- ISIN
- CA45569M1095
- Listed since
- Sep 12, 2014
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.